Anzeige
Mehr »
Login
Sonntag, 23.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
851 % Rendite in 30 Tagen: Die KI-Aktie, die seit der Integration von Deepseek R1 Wellen schlägt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J20J | ISIN: US44934S2068 | Ticker-Symbol: HWT1
NASDAQ
21.02.25
21:58 Uhr
2,715 US-Dollar
-0,115
-4,06 %
1-Jahres-Chart
ICAD INC Chart 1 Jahr
5-Tage-Chart
ICAD INC 5-Tage-Chart

Aktuelle News zur ICAD Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FriCAD, Inc. (ICAD): A Bull Case Theory2
MiiCAD Shares Unchanged Ahead of Presentations-
ICAD Aktie jetzt für 0€ handeln
MiiCAD, Inc.: iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 20251
04.02.Why iCAD Inc (ICAD) Is Skyrocketing So Far In 20255
01.02.iCAD, Inc. (NASDAQ:ICAD) Short Interest Down 14.5% in January1
27.01.iCAD-Aktie erreicht 52-Wochen-Hoch von 2,67 US-Dollar2
27.01.iCAD expects Q4 revenue higher than consensus3
27.01.iCAD, Inc.: iCAD Pre-Announces Estimated Q4 2024 Revenue224iCAD to Participate in the BTIG at Snowbird:12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference NASHUA, N.H., Jan. 27, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD)...
► Artikel lesen
11.12.24iCAD, Inc.: SABCS 2024: New Research Assesses iCAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations13
26.11.24iCAD, Inc.: iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024100NASHUA, N.H., Nov. 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company"), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking...
► Artikel lesen
12.11.24Earnings Outlook For icad3
12.11.24FDA clears AI-powered breast cancer detection tech from iCad2
12.11.24iCAD erhält FDA-Zulassung für KI-gestütztes Brustkrebserkennungstool5
12.11.24iCAD AI breast cancer detection tool gains FDA approval3
05.11.24iCAD, Inc.: iCAD to Report Third Quarter 2024 Financial Results on November 13, 20243
16.10.24iCAD to Participate in the LD Micro Main Event XVII249Nashua, New Hampshire--(Newsfile Corp. - October 16, 2024) - iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing...
► Artikel lesen
03.10.24iCAD, Inc.: iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 20241
11.09.24iCAD, Inc.: iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 20241
08.04.24iCAD, Inc.: iCAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting1.041NASHUA, N.H., April 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today that new data indicates its...
► Artikel lesen
12.03.24iCAD, Inc.: iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results466Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-yearFull-Year Operating Cash Flow ($5) million vs. ($12.8) million prior yearYear ending cash balance of $21.7M NASHUA, N.H....
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1